24 results on '"Gaouar Farid"'
Search Results
2. Low-phospholipid-associated cholelithiasis syndrome: Prevalence, clinical features, and comorbidities
3. Liver Steatosis Assessed by Controlled Attenuation Parameter (CAP) Measured with the XL Probe of the FibroScan: A Pilot Study Assessing Diagnostic Accuracy
4. Anticorps anti-gp210 et anticorps anti-Sp100 dans la cirrhose biliaire primitive : une association de très mauvais pronostic
5. Contribution of Liver Stiffness Measurement by Vibration-Controlled Transient Elastography to Outcome Prediction in Primary Biliary Cholangitis
6. Liver stiffness measurement by vibration-controlled transient elastography improves outcome prediction in primary biliary cholangitis
7. Large‐scale characterization study of patients with antimitochondrial antibodies but nonestablished primary biliary cholangitis
8. Évaluation de l'incidence de la cirrhose biliaire primitive en 2007 en France
9. Is biochemical response to ursodeoxycholic acid therapy impacted by vitamin D plasma level in patients with primary biliary cirrhosis?: 2036
10. Noninvasive elastography-based assessment of liver fibrosis progression and prognosis in primary biliary cirrhosis
11. FRI-009-Bezafibrate add-on therapy in high-risk primary biliary cholangitis is associated with prolonged predicted survival even in patients with incomplete biochemical improvements
12. The Complementary Value of Magnetic Resonance Imaging and Vibration-Controlled Transient Elastography for Risk Stratification in Primary Sclerosing Cholangitis
13. PS-185-Magnetic resonance risk score and liver stiffness by transient elastography have complementary prognostic values in patients with primary sclerosing cholangitis
14. Estimated risk reduction of mortality and transplantation with bezafibrate in patients with PBC and inadequate response to UDCA: application of the UK-PBC and Global PBC risk scores to the BEZURSO trial
15. Refinement of diagnostic criteria and frequency estimation of LPAC syndrome: A French multicenter study
16. FRI-010-Bezafibrate add-on therapy in high-risk primary biliary cholangitis is associated with an improvement of fibrometer and fibrometer-VCTE, two high-accuracy non-invasive fibrosis tests extensively validated in frequent chronic liver diseases
17. FRI-036-Perception by patients with autoimmune and chronic cholestatic disease of their own health condition: Results of a survey led by the French patient association (ALBI)
18. Primary sclerosing cholangitis response to the combination of fibrates with ursodeoxycholic acid: French–Spanish experience
19. A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis
20. Large-scale characterization study of patients with antimitochondrial antibodies but nonestablished primary biliary cholangitis.
21. Baseline Values and Changes in Liver Stiffness Measured by Transient Elastography Are Associated With Severity of Fibrosis and Outcomes of Patients With Primary Sclerosing Cholangitis
22. Smoking as an independent risk factor of liver fibrosis in primary biliary cirrhosis
23. Liver stiffness measurement by vibration-controlled transient elastography improves outcome prediction in primary biliary cholangitis
24. Low-phospholipid-associated cholelithiasis syndrome: Prevalence, clinical features, and comorbidities.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.